Fusion Pharmaceuticals Inc.
FUSNDelisted Jun 5, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001805890
Fusion Pharmaceuticals Inc. was delisted on Jun 5, 2024; its insiders filed their last Form 4 on Jun 4, 2024; 114 institutions reported holding it in 13F filings for Q1 2024, worth $1.47B in total; Duquesne Family Office was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Fusion Pharmaceuticals Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +3 vs. Q2 2022
- Shares held
- 26.6M
- −1.28M (−4.6%) vs. Q2 2022
- Total value
- $80.3M
- +$10.9M (+15.8%) vs. Q2 2022
- New holders
- 8
- 7 more added
- Sold out
- 5
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FUSN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 114 | $1.47B |
| Q4 2023 | 77 | $584.1M |
| Q3 2023 | 41 | $129.8M |
| Q2 2023 | 41 | $235.1M |
| Q1 2023 | 38 | $171.9M |
| Q4 2022 | 30 | $88.9M |
| Q3 2022 | 34 | $80.3M |
| Q2 2022 | 31 | $69.4M |
| Q1 2022 | 28 | $219.1M |
| Q4 2021 | 32 | $116.0M |
| Q3 2021 | 40 | $220.6M |
| Q2 2021 | 39 | $221.8M |
| Q1 2021 | 38 | $295.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Fusion Pharmaceuticals Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 2 | $0 | 0.00% | −4,350−100.0% | Reduced |
| Simplex Trading, LLC | 100 | $0 | 0.00% | +100 | New |
| Paragon Wealth Strategies, LLC | 30 | $0 | 0.00% | +30 | New |
| American Portfolios Advisors | 30 | $90 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 300 | $1.00K | 0.00% | 00.0% | Unchanged |
| Truvestments Capital LLC | 335 | $1.00K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 875 | $2.85K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 850 | $3.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 2,900 | $9.00K | 0.00% | +2,900 | New |
| BlackRock Inc. | 8,253 | $25.0K | 0.00% | 00.0% | Unchanged |
| Prudential Financial Inc | 14,600 | $44.0K | 0.00% | +14,600 | New |
| Renaissance Technologies LLC | 16,800 | $51.0K | 0.00% | +16,800 | New |
| UBS Oconnor LLC | 17,286 | $52.0K | 0.00% | +17,286 | New |
| Geode Capital Management, LLC | 25,136 | $75.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 28,494 | $86.0K | 0.00% | +28,494 | New |
| Victory Capital Management Inc | 50,390 | $152.0K | 0.00% | −131,010−72.2% | Reduced |
| UBS Group AG | 54,904 | $165.0K | 0.00% | +34,350+167.1% | Added |
| Sectoral Asset Management Inc | 57,297 | $172.0K | 0.03% | +19,099+50.0% | Added |
| Morgan Stanley | 76,677 | $231.0K | 0.00% | +17,855+30.4% | Added |
| Sofinnova Investments, Inc. | 117,099 | $352.0K | 0.02% | +39,033+50.0% | Added |
| Tekla Capital Management LLC | 101,931 | $605.0K | 0.02% | +58,537+134.9% | Added |
| Sio Capital Management, LLC | 260,448 | $784.0K | 0.33% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 310,068 | $933.0K | 0.00% | −18,800−5.7% | Reduced |
| Ra Capital Management, L.P. | 659,992 | $1.99M | 0.04% | +659,992 | New |
| 1832 Asset Management L.P. | 734,321 | $2.21M | 0.00% | 00.0% | Unchanged |
| Artal Group S.A. | 750,000 | $2.26M | 0.12% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,984 | $4.70M | 1.72% | +20.0% | Added |
| TPG GP A, LLC | 2,551,794 | $7.68M | 0.13% | 00.0% | Unchanged |
| Adams Street Partners LLC | 2,947,809 | $8.87M | 2.43% | 00.0% | Unchanged |
| FMR LLC | 3,046,813 | $9.17M | 0.00% | −203,867−6.3% | Reduced |
| Canada Pension Plan Investment Board | 3,116,966 | $9.38M | 0.02% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 3,174,100 | $9.55M | 0.03% | +50,000+1.6% | Added |
| OrbiMed Advisors LLC | 3,224,770 | $9.71M | 0.19% | 00.0% | Unchanged |
| Johnson & Johnson | 3,670,516 | $11.0M | 3.25% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,052,445−100.0% | Sold out |
| Rock Springs Capital Management LP | 0 | $0 | 0.00% | −809,854−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −11,722−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,259−100.0% | Sold out |
| Heritage Financial Services, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |